Answers are grounded in this paper and cite their sources.
BACKGROUND: Multiple system atrophy (MSA) is primarily characterized by subcortical neurodegeneration. However, neuropathological evidence indicates that cortical neurodegeneration is also part of the disease. Conventional neuroimaging measures, such as cortical thickness (CTh), have been used to assess cortical macrostructural alterations, but findings remain limited and inconclusive. In this context, cortical mean diffusivity (cMD) has emerged as a promising marker of microstructural integrity, capturing alterations beyond macrostructural changes in other neurodegenerative disorders. However, its role in MSA remains largely unexplored. OBJECTIVES: The objective of the study was to characterize cortical macro- and microstructural alterations in MSA and assess associations with clinical severity and cognitive performance. METHODS: T1-weighted and diffusion magnetic resonance imaging (MRI), clinical, and neuropsychological assessments were obtained in 29 patients with MSA and 35 age- and sex-matched controls (HCs). Cortical macro- and microstructural alterations were evaluated using CTh and cMD, respectively. Group comparisons and correlations between MRI-derived cortical measures and clinical, cognitive, and neurodegeneration biomarkers were conducted (P < 0.05, false discovery rate [FDR]-corrected). RESULTS: Patients with MSA exhibited widespread increases in cMD, predominantly affecting the frontal and temporal cortices. This pattern partially overlapped with cortical thinning, although cMD alterations extended to rostral-lateral, rostral-medial, and inferior-medial regions. In MSA, increased cMD was associated with global cognitive impairment, whereas cortical thinning correlated with disease severity. CONCLUSIONS: MSA involves concurrent macro- and microstructural cortical alterations, with microstructural changes potentially preceding overt atrophy and indicating early pathology. Distinct cMD and CTh patterns suggest partially independent processes, whereas differential clinical associations highlight their complementarity. Together, these markers improve the characterization of cortical degeneration and disease heterogeneity.
No takes yet. Share an insight, caveat, or question.
Pardo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: